Special Feature

User Panel

My Panel

My Panel

Bookmark Science Articles

Recent News
Bookmark / Share This Science Site

Comparison of treatment outcomes of childhood Hodgkin lymphoma in two US centers and a center in Recife, Brazil.

Comparison of treatment outcomes of childhood Hodgkin lymphoma in two US centers and a center in Recife, Brazil. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

  • Abstract Text of This Paper
  • Journal Published
  • MeSH Keywords of This Abstract
  • Chemicals and Substances Used in this Paper
  • Grants and Granting Agency of this Research
  • Database Accession Numbers Used in this Paper
  • Related Papers
  • Related Research Tags
  • Rate this Research Paper
  • Comparison of treatment outcomes of childhood Hodgkin lymphoma in two US centers and a center in Recife, Brazil. Abstract Text:

    saunders c hsuSaunders C Hsu,monika l metzgerMonika L Metzger,melissa m hudsonMelissa M Hudson,francisco pedrosaFrancisco Pedrosa,mecneide linsMecneide Lins,marcia pedrosaMarcia Pedrosa,cynthia barrosCynthia Barros,kaline macielKaline Maciel,ching-hon puiChing-Hon Pui,raul c ribeiroRaul C Ribeiro,scott c howardScott C Howard,

    BACKGROUND: Pediatric Hodgkin lymphoma (HL) has a cure rate of more than 80% in high-income countries (HIC). However, more than 80% of the world's children live in low-income countries (LIC), where the cure rate is often much lower. PROCEDURE: We compared the outcome of HL of 371 patients treated at two pediatric oncology centers in the US to that of 62 patients treated at one center in Recife, Brazil (IMIP) to determine whether the same treatment strategy should be used in both high-income and LIC. The logrank test was used to compare event-free and overall survival. RESULTS: The percentages of patients with unfavorable disease at each center were similar (P = 0.72). Patients with favorable disease at IMIP had estimated 5-year survival rates comparable to those of the US centers (100% and 99%, respectively). Among patients with unfavorable disease, those treated at IMIP had a 5-year event-free survival (EFS) rate of 60%, compared to 78% at the US centers; (P = 0.08). The 5-year survival estimate after relapse was 25% at IMIP versus 61% at the US centers (P = 0.08). The 5-year overall survival for patients with unfavorable disease was 72% at IMIP versus 90% at the US centers (P = 0.01). CONCLUSIONS: Intensive frontline therapy should be considered for patients with unfavorable HL in LIC where the relapse rate is high and the salvage rate is low, provided that supportive care is adequate.

    Comparison of treatment outcomes of childhood Hodgkin lymphoma in two US centers and a center in Recife, Brazil. Publishing Authors By Initials

    sc hsuSC Hsu,ml metzgerML Metzger,mm hudsonMM Hudson,f pedrosaF Pedrosa,m linsM Lins,m pedrosaM Pedrosa,c barrosC Barros,k macielK Maciel,ch puiCH Pui,rc ribeiroRC Ribeiro,sc howardSC Howard,

    For similar heterocyclic compounds: alkaloids: indole alkaloids: secologanin tryptamine alkaloids: vinca alkaloids: vincristine research abstracts see: heterocyclic compounds: alkaloids: indole alkaloids: secologanin tryptamine alkaloids: vinca alkaloids: vincristine research

    PUBMED ID PMID:

    MEDLINE DATE:

    Comparison of treatment outcomes of childhood Hodgkin lymphoma in two US centers and a center in Recife, Brazil. Journal Published:

    PUBLICATION TYPE: Research Support, Non-U.S. Gov

    Journal: Pediatric blood & cancer

    VOLUME: 49

    Page Numbers: 139-44

    Journal Abbreviation:

    ISSN: 1545-5009

    DAY: 3

    MONTH: Aug

    YEAR: 2007

    Comparison of treatment outcomes of childhood Hodgkin lymphoma in two US centers and a center in Recife, Brazil. Information

    Number of References:

    LANGUAGE: eng

    NlmUniqueID: 101186624

    Comparison of treatment outcomes of childhood Hodgkin lymphoma in two US centers and a center in Recife, Brazil. Keywords Mesh Terms:

    KEYWORDS: Vincristine

    MESH TERMS: administration & dosage

    Chemical & Substance for Abstract: Comparison of treatment outcomes of childhood Hodgkin lymphoma in two US centers and a center in Recife, Brazil. Information

    Substance Name: Vinblastine

    Registry Number: 865-21-4

    Grant and Affiliation Information for Comparison of treatment outcomes of childhood Hodgkin lymphoma in two US centers and a center in Recife, Brazil.

    AFFILIATION: Department of Pediatrics, Division of Pediatric Hematology-Oncology, Doernbecher Children's Hospital, Oregon Health & Science University, Portland, Oregon, USA. hsus@ohsu.edu

    Country: United States

    United States Research PublicationUnited States Research Publication

    AGENCY: United States NCI

    GRANT: R01-CA600419

    ACRONYM: CA

    MEDLINETA: Pediatr Blood Cancer

    REFSOURCE:

    DATABASENAME:

    ACCESSION NUMBER:

    Number Hits: 0

    Comparison of treatment outcomes of childhood Hodgkin lymphoma in two US centers and a center in Recife, Brazil Related Publications

     

    Molecular Station USER Menu

    Welcome to Molecular Station!

    You have to register before you can post on our forums or use our advanced features. Register Now! Its Free and Fast!

    Already registered? Login now below.

    User Name:

    Password:

    Already registered and Forgot your password? Click below to recover it.

    Recover Lost Password

    Join now - it's fast and free!

    Molecular Station is THE largest network of researchers, scientists and science lovers anywhere!

    Research Terms of Usage and Disclaimer
    Home
    Features

    Protocols

    DNA Forum

    Science Forum

    DNA Forum
    Biology Forum

    Science News


    [CaRP] XML error: Invalid document end at line 2

    For more click here:Science News